title: Survival and progression to AIDS in a seroconverter cohort in the post-highly active antiretroviral therapy era: effectiveness goes on.
abstract: Progression to AIDS and death for 1129 HIV seroconverters from the GEMES cohort were analysed by calendar period (1996-1997, 1998-1999, 2000 onwards). A further hazard reduction was observed for a later period for both. Intravenous drug users (IDU) had a faster progression. The results highlighted the importance of monitoring the effectiveness of highly active antiretroviral therapy and to improve public health strategies directed to IDU to reduce inequity in HIV infection care.
authors.affiliation: Valencian School of Health Studies (EVES), Valencia, Spain.
authors.forename: Santiago
authors.initials: S
authors.lastname: Pérez-Hoyos
authors.forename: Inma
authors.initials: I
authors.lastname: Ferreros
authors.forename: Julia
authors.initials: J
authors.lastname: del Amo
authors.forename: Roberto
authors.initials: R
authors.lastname: Muga
authors.forename: Jorge
authors.initials: J
authors.lastname: del Romero
authors.forename: Patricia Garcia
authors.initials: PG
authors.lastname: de Olalla
authors.forename: Ildefonso
authors.initials: I
authors.lastname: Hernández-Aguado
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000401:mortality / Q000517:prevention & control*; D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D018450:Disease Progression; D004812:Epidemiologic Methods; D005260:Female; D006679:HIV Seropositivity / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D008297:Male; D013030:Spain / Q000453:epidemiology; D015819:Substance Abuse, Intravenous / Q000150:complications; D016896:Treatment Outcome